Skip to main content
Clinical Trials/ACTRN12618000464268
ACTRN12618000464268
Completed
N/A

Abdominal Functional Electrical Stimulation to improve bowel and bladder function in Multiple Sclerosis

euroscience Research Australia0 sites23 target enrollmentMarch 29, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
euroscience Research Australia
Enrollment
23
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2018
End Date
April 19, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
euroscience Research Australia

Eligibility Criteria

Inclusion Criteria

  • Adults with diagnosed MS and an Expanded Disability Status Scale score of 3 to 8, who are able to eat and drink normally, fulfil the Rome III criteria for functional constipation, and constipated for at least three months.

Exclusion Criteria

  • Current urinary tract infection, pregnancy, history of irritable bowel syndrome, organic bowel obstruction or other bowel disease, physical obstacles that prevent Abdominal FES (e.g. abdominal trauma, pacemaker), no response to Abdominal FES (e.g. lower motor neuron impairment), taking medication designed to alter bowel or bladder function.

Outcomes

Primary Outcomes

Not specified

Similar Trials